US Stocks
/
BioCryst Pharmaceuticals, Inc. Share Price

BioCryst Pharmaceuticals, Inc. Share Price

NASDAQ: BCRX | Small Cap
$8.55
+$0.26 (3.13%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BioCryst Pharmaceuticals, Inc. Stock Performance

Open
$8.30
Prev. Close
$8.29
Circuit Range
N/A
Day Range
$8.30 - $8.59
Year Range
$6.00 - $11.21
Volume
2,17,546
Average Traded
$8.51

BioCryst Pharmaceuticals, Inc. Share Price Today

As of 11 October 2026, BioCryst Pharmaceuticals, Inc.'s share price is $8.55. The stock opened at $8.30, compared to its previous close of $8.29. During today's trading session, BioCryst Pharmaceuticals, Inc.'s share price traded between $8.30 and $8.59, with an average price of $8.45. Over the past 52 weeks, the stock has recorded a high of $11.21 and a low of $6.00. In terms of performance, BioCryst Pharmaceuticals, Inc.'s share price has declined by 6.60% over the last six months and is up 16.87% on a year-on-year basis.

BioCryst Pharmaceuticals, Inc. Share Price Chart

$8.30$8.59
L
Show Current Price
H

BioCryst Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.80B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.51
Revenue (TTM)
$874.84B
Return On Equity (TTM)
84.68%
Profit Margin
30.16%
Debt to Equity
-1.81
Quarterly Earnings Growth YoY
507.75%

BioCryst Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$159.40$406.56$156.41$218.25
Net Profit$12.90$245.85-$721.81$78.40
Net Profit Margin8.09%60.47%-461.49%35.92%
Income ChangeN/A1805.81%-393.60%110.86%

BioCryst Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$270.83$331.41$450.71$874.84
Net Profit-$247.12-$226.54-$88.88$263.86
Net Profit Margin-91.25%-68.36%-19.72%30.16%
Income ChangeN/A8.33%60.77%396.87%

About BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

BioCryst Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$8.28
$8.56
+2.95%
Sep 2026
$9.70
$8.31
-15.75%
Aug 2026
$8.96
$9.87
+10.03%
Jul 2026
$10.05
$8.97
-10.30%
Jun 2026
$8.81
$10.00
+12.04%
May 2026
$9.15
$8.93
-2.57%
Apr 2026
$9.54
$9.16
-3.78%
Mar 2026
$8.62
$9.52
+8.80%
Feb 2026
$6.53
$8.75
+33.08%
Jan 2026
$7.83
$6.58
-15.81%
Dec 2025
$7.06
$7.81
+8.77%
Nov 2025
$7.07
$7.18
-1.91%

BCRX Share Price FAQs

What is BioCryst Pharmaceuticals, Inc. share price today?

chevron-up
BioCryst Pharmaceuticals, Inc. share price today is $8.55 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BioCryst Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of BioCryst Pharmaceuticals, Inc. stock is $11.21, while the 52 week low is $6.00 as of 10 Oct '26.

What is BCRX's market capitalisation today?

chevron-up
BCRX market capitalisation is $1.80B as of October 11, 2026, at 2:06 am IST.

What is BCRX's net income for the last quarter?

chevron-up
BCRX's net income for the last quarter is 78.40B USD.

What is the 5 year returns of BCRX?

chevron-up
The 5 year returns of BCRX is -42.70% as on 10 Oct '26.

What is the high & low stock price of BCRX today?

chevron-up
BCRX stock price hit a high of $8.59 and low of $8.30 as of 10 Oct '26.

Can I buy BCRX shares in India?

chevron-up
Yes. You can buy BCRX in India by opening an international trading account.